Structural and symptomatic benefit of a half-live extended, systemically applied anti-ADAMTS-5 inhibitor (M6495)
| Autor: | Brenneis, C. †, Serruys, B. ‡, Van Belle, T. ‡, Poelmans, S. ‡, Kleinschmidt-Doerr, K. †, Guehring, H. †, Michaelis, M. †, Lindemann, S. † |
|---|---|
| Zdroj: | In Osteoarthritis and Cartilage April 2018 26 Supplement 1:S299-S300 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect